Last reviewed · How we verify
NCT06016673
Testing a Causal Model of Cognitive Control Deficits in Posttraumatic Stress Disorder (PTSD)
NA trial testing Transcranial Magnetic Stimulation (TMS) in PTSD in 40 participants. Completed in 3 February 2024.
3 February 2024
Quick facts
| Lead sponsor | Florida State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | basic science |
| Enrollment | 40 |
| Start date | 13 September 2023 |
| Primary completion | 3 February 2024 |
| Estimated completion | 3 February 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Transcranial Magnetic Stimulation (TMS)
Conditions studied
- PTSD — all drugs for PTSD →
Sponsor
Florida State University
Who can join
Adults 18 to 65, any sex, with PTSD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Testing a Causal Model of Cognitive Control Deficits in Posttraumatic Stress Disorder (PTSD)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06016673
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcranial Magnetic Stimulation (TMS)
Trials testing the same drug.
- NCT05861284 — Developing and Optimizing Transcranial Magnetic Stimulation for Motor Rehabilitation · NA · withdrawn
- NCT07250464 — Motor Evoked Potential and Cortical Silent Period in Migraine · NA · not yet recruiting
- NCT07110493 — Study of Visual Perception Phenomena: Phosphene Mapping Induced by TMS and Its Relationship With Eye Movements · NA · recruiting
- NCT06960083 — Transcranial Magnetic Stimulation in Misophonia · NA · recruiting
- NCT07179406 — The Effect of Spinal Cord Stimulators on Restless Leg Syndrome · NA · recruiting
Other recruiting trials for PTSD
Currently open trials in the same condition.
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
- NCT07010757 — Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial · NA · recruiting
- NCT07372586 — Behavioral Health Collaborative Care Model in an ICU Recovery Clinic · NA · recruiting
- NCT07390786 — Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot · NA · recruiting
- NCT07469098 — Group vs Individual MDMA-Assisted Therapy for PTSD After the October 7, 2023 Events · Phase 2 · recruiting
Other Florida State University trials
Trials by the same sponsor.
- NCT06127914 — Learning Early Infant Feeding Cues · NA · not yet recruiting
- NCT06015581 — Scaling Up Implementation Strategies to Improve the DIAGNOSE and PREVENT Pillars for Young MSM in Florida · NA · not yet recruiting
- NCT07467473 — Causal Role of Rostromedial Prefrontal Cortex for Positive Savoring in Depression · NA · enrolling by invitation
- NCT07221448 — Sodium vs Potassium Education to Improve Vascular Health · NA · recruiting
- NCT07415941 — MBM and taVNS for Low Back Pain and Depressive Symptoms · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06016673 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Florida State University
- Last refreshed: 15 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06016673.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing